Radiobiological speculations on therapeutic total body irradiation.
Unexpected total body irradiation (TBI) of human beings, involved in nuclear warfare or in accidents in nuclear reactors can be lethal. In the 1950s, bone marrow transplantation was discovered as a potentially life saving procedure after TBI in the dose range of 5.0 to 12.0 Gy. Since that time, deliberate or "therapeutic" TBI has been used to condition patients with a lethal bone marrow disorder for bone marrow replacement. The therapeutic ratio of TBI followed by bone marrow transplantation is small. Many potentially lethal complications can occur, such as acute TBI side effects, late TBI side effects or immunological complications of bone marrow transplantation such as graft versus host disease or graft rejection. The benefits of TBI and bone marrow transplantation are that they offer a chance for cure of previously lethal bone marrow disorders. The optimal parameters for TBI remain to be defined. The review discusses the current clinical and experimental animal data, as they relate to the future definition of less toxic TBI procedures with a better therapeutic ratio. Different TBI procedures are required for patients with malignant vs. non-malignant disorders or for patients with histoincompatible vs. histocompatible bone marrow donors.
Vriesendorp
H M
HM
Department of Radiation Oncology, Johns Hopkins Hospital, Baltimore, Maryland 21205.
D000818:Animals; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D011830:Radiation Effects; D011835:Radiation Protection / Q000379:methods; D011879:Radiotherapy Dosage; D014916:Whole-Body Irradiation / Q000009:adverse effects / Q000379:methods*